239 related articles for article (PubMed ID: 9151381)
1. Thymic interdigitating cells express thioredoxin (TRX/ADF): an immunohistochemical study of 82 thymus and thymoma samples.
Go T; Isowa N; Hirata T; Yodoi J; Hitomi S; Wada H
Thymus; 1997; 24(3):157-71. PubMed ID: 9151381
[TBL] [Abstract][Full Text] [Related]
2. Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: independence of tubular necrosis and sulfhydryl depletion.
Tanaka T; Nishiyama Y; Okada K; Hirota K; Matsui M; Yodoi J; Hiai H; Toyokuni S
Lab Invest; 1997 Aug; 77(2):145-55. PubMed ID: 9274857
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of immature CD3-CD4+CD8- single-positive cells that lack CD69 in epithelial cell tumors of the human thymus.
Takeuchi Y; Fujii Y; Okumura M; Inada K; Nakahara K; Matsuda H
Cell Immunol; 1995 Apr; 161(2):181-7. PubMed ID: 7697728
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical study of thymic epithelial tumors. III. The distribution of interdigitating reticulum cells and S-100 beta-positive small lymphocytes.
Kondo K; Mukai K; Sato Y; Matsuno Y; Shimosato Y; Monden Y
Am J Surg Pathol; 1990 Dec; 14(12):1139-47. PubMed ID: 2252104
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical study of 11 epithelial tumors of the thymus or thymomas with anti-keratin antibodies: KL-1].
Caillaud JM; Carlu C; Bretel JJ; Arriagada R
Rev Mal Respir; 1988; 5(2):153-7. PubMed ID: 2455924
[TBL] [Abstract][Full Text] [Related]
6. Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour.
Chang KC; Wu MH; Jones D; Chen FF; Tseng YL
J Pathol; 2006 Oct; 210(2):224-33. PubMed ID: 16917804
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma.
Dorfman DM; Shahsafaei A; Miyauchi A
Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728
[TBL] [Abstract][Full Text] [Related]
8. Immunohistological analysis of thymic tumors with PE-35 monoclonal antibody reactive with medullary thymic epithelium.
Takahashi T; Ueda R; Nishida K; Namikawa R; Fukami H; Matsuyama M; Masaoka A; Imaizumi M; Takahashi T
Cancer Res; 1988 Apr; 48(7):1896-903. PubMed ID: 2450640
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors.
U-Taniguchi Y; Furuke K; Masutani H; Nakamura H; Yodoi J
Oncol Res; 1995; 7(3-4):183-9. PubMed ID: 8555652
[TBL] [Abstract][Full Text] [Related]
10. IL-1 mRNA expression detected by in situ hybridization and polymerase chain reaction in human thymus and thymoma. Correlation with late T-cell maturation in normal versus neoplastic thymus.
Aime C; Bristol L; Cohen-Kaminsky S; Berrih-Aknin S; Durum S; Takács L
Thymus; 1993 Aug; 22(1):45-54. PubMed ID: 8303777
[TBL] [Abstract][Full Text] [Related]
11. The role of the reticulo-epithelial (RE) cell network in the immuno-neuroendocrine regulation of intrathymic lymphopoiesis.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 2000; 20(3A):1871-88. PubMed ID: 10928121
[TBL] [Abstract][Full Text] [Related]
12. Proliferative activity and apoptosis in thymic epithelial neoplasms.
Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus.
Cimpean AM; Raica M; Encica S; Cornea R; Bocan V
Ann Anat; 2008; 190(3):238-45. PubMed ID: 18356031
[TBL] [Abstract][Full Text] [Related]
14. Distribution of molecules mediating thymocyte-stroma-interactions in human thymus, thymitis and thymic epithelial tumors.
Marx A; Schömig D; Schultz A; Gattenlöhner S; Jung A; Kirchner T; Melms A; Müller-Hermelink HK
Thymus; 1994; 23(2):83-93. PubMed ID: 7725387
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
[TBL] [Abstract][Full Text] [Related]
16. CD5 expression in thymic carcinoma.
Hishima T; Fukayama M; Fujisawa M; Hayashi Y; Arai K; Funata N; Koike M
Am J Pathol; 1994 Aug; 145(2):268-75. PubMed ID: 7519823
[TBL] [Abstract][Full Text] [Related]
17. Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex.
Savino W; Manganella G; Verley JM; Wolff A; Berrih S; Levasseur P; Binet JP; Dardenne M; Bach JF
J Clin Invest; 1985 Sep; 76(3):1140-6. PubMed ID: 2413072
[TBL] [Abstract][Full Text] [Related]
18. Redox regulation of cellular activation.
Nakamura H; Nakamura K; Yodoi J
Annu Rev Immunol; 1997; 15():351-69. PubMed ID: 9143692
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of p63 and XIAP in thymic hyperplasia and thymomas.
Wu M; Sun K; Gil J; Gan L; Burstein DE
Am J Clin Pathol; 2009 May; 131(5):689-93. PubMed ID: 19369629
[TBL] [Abstract][Full Text] [Related]
20. Thymoma with abundant L26-positive 'asteroid' cells. A case report with an analysis of normal thymus and thymoma specimens.
Taubenberger JK; Jaffe ES; Medeiros LJ
Arch Pathol Lab Med; 1991 Dec; 115(12):1254-7. PubMed ID: 1768216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
